News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Nussbaum Ran
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 02/28/2023 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 2,211 options to buy
@ $5, valued at
$11.1k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 32,723 options to buy
@ $5.94, valued at
$194.4k
Exercised 15,276 options to buy
@ $5.94, valued at
$90.7k
|
|
| 08/25/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 6,817 options to buy
@ $7.06, valued at
$48.1k
Granted 3,183 options to buy
@ $7.06, valued at
$22.5k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 2,211 options to buy
@ $5, valued at
$11.1k
Granted 6,817 options to buy
@ $17.89, valued at
$122k
Granted 3,183 options to buy
@ $17.89, valued at
$56.9k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 01/26/2021 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 1,576,881 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 11/19/2020 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Bought 26,634 shares
@ $50, valued at
$1.3M
Bought 12,966 shares
@ $50, valued at
$648.3k
Bought 14,400 shares
@ $50, valued at
$720k
Bought 6,000 shares
@ $50, valued at
$300k
|
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 05/22/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
|
|
| 04/13/2020 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Converted 1,363,542 shares
@ $0
Converted 663,825 shares
@ $0
Converted 737,226 shares
@ $0
Converted 169,307 shares
@ $0
Converted 82,425 shares
@ $0
Converted 91,538 shares
@ $0
Converted 68,654 shares
@ $0
Converted 163,612 shares
@ $0
Converted 88,460 shares
@ $0
Converted 79,653 shares
@ $0
Converted 36,858 shares
@ $0 |
|
| 01/16/2020 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Unknown transaction of 2,319,920 shares
@ $20, valued at
$46.4M
Unknown transaction of 4,290,550 shares
@ $20, valued at
$85.8M
Unknown transaction of 2,088,816 shares
@ $20, valued at
$41.8M
Unknown transaction of 36,923 shares
@ $20, valued at
$738.5k
Unknown transaction of 8,611 shares
@ $20, valued at
$172.2k
Disposed/sold 30,000 options to buy
@ $1.1, valued at
$33k
Disposed/sold 20,000 options to buy
@ $2.48, valued at
$49.6k
Disposed/sold 40,000 options to buy
@ $6.21, valued at
$248.4k
|
|
| 12/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2019 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Exercised (in-or-at-the-money) 30,476 warrants
@ $1.75, valued at
$53.3k
Exercised (in-or-at-the-money) 56,368 warrants
@ $1.75, valued at
$98.6k
Exercised (in-or-at-the-money) 27,442 warrants
@ $1.75, valued at
$48k
|
|
| 07/01/2019 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Bought 133,548 shares
@ $9.75, valued at
$1.3M
Bought 65,016 shares
@ $9.75, valued at
$633.9k
Bought 72,205 shares
@ $9.75, valued at
$704k
Bought 36,923 shares
@ $9.75, valued at
$360k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $34.83, valued at
$348.3k
|
|
| 05/29/2019 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
|
|
| 05/15/2019 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 40,000 options to buy
@ $6.21, valued at
$248.4k
|
|
| 10/22/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Bought 48,485 shares
@ $5.5, valued at
$266.7k
Bought 89,676 shares
@ $5.5, valued at
$493.2k
Bought 43,657 shares
@ $5.5, valued at
$240.1k
|
|
| 06/19/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $23.27, valued at
$930.8k
|
|
| 05/25/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Acquired 1,762,000 shares
@ $0
Acquired 3,259,000 shares
@ $0
Acquired 1,587,000 shares
@ $0
Acquired 476,000 warrants
@ $1.75, valued at
$833k
Acquired 880,000 warrants
@ $1.75, valued at
$1.5M
Acquired 428,000 warrants
@ $1.75, valued at
$749k
|
|
| 05/18/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Bought 8,611 shares
@ $3.29, valued at
$28.3k
|
|
| 05/10/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 20,000 options to buy
@ $2.48, valued at
$49.6k
|
|
| 05/01/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 84,041 shares
@ $9.75, valued at
$819.4k
Bought 172,626 shares
@ $9.75, valued at
$1.7M
Bought 93,333 shares
@ $9.75, valued at
$910k
|
|
| 03/23/2018 |
4
| Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 1,585 shares
@ $7.55, valued at
$12k
Bought 3,255 shares
@ $7.55, valued at
$24.6k
Bought 1,760 shares
@ $7.55, valued at
$13.3k
Bought 1,441 shares
@ $8, valued at
$11.5k
Bought 2,959 shares
@ $8, valued at
$23.7k
Bought 1,600 shares
@ $8, valued at
$12.8k
|
|
|
|
|